That's essential, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (jeff brown stock predictions). Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was an advancement almost no one noticed. However it's going to have profound implications for treating illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of financial investment opportunities in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (exponential tech investor). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps considerably prior to going greater - last week. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. However that's not the huge concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. melania trump. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are many great private companies on the brink of hitting the general public markets And I have actually been dealing with a new way for you to invest even prior to these companies go public.
This chance has been developing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the information. Go right here to reserve your spot free of charge.
Emma Walsh here, managing editor of the Journal. Regular Diary readers know that tech isn't our normal beat (tech stock). And when it pertains to tech investing, we leave it to the professionals. Luckily, we have numerous such experts in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing specialists we understand (legacy report prediction). In fact, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and much more. These patterns are experiencing rapid growth and creating amazing opportunities for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. democratic republic. But in spite of what numerous readers might believe, this is a trend that's simply beginning. Although the COVID-19 pandemic disrupted supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (social media). Losing 2 months of production and sales really impacts how lots of 5G gadgets are offered in the fiscal year. When you think about all of that, offering 250 million systems is exceptional. More importantly, the hold-ups caused by the pandemic created a lots of bottled-up need. Which need is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G gadgets will be shipped in 2021 - bleeding edge. Which's not my only 5G forecast When I've spoken about 5G in the past, I have actually described its three various stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Phase Three, 5G services begin to be offered (social media). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase Three by this summer season. This begins something of a virtuous cycle: Many people don't really care about the innovation. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open up a suite of unbelievable applications: self-driving cars, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment chances going forward will be massive. Stepping far from 5G, the next crucial technology I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can cause illness. CRISPR can remedy these "typos." For years, CRISPR was mainly a niche innovation that wasn't well comprehended. And throughout that time, there were really just 3 business operating in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with diseases and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This whole market is successfully a greenfield opportunity.
There's space for lots of business to exist in this space. white house. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software can properly predict the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That's important due to the fact that the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error procedure. And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however numerous drug treatments produced using this innovation. This was among those advancements that almost no one noticed. However it's going to have extensive implications for curing disease. And, obviously, there will be a lot of investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it pulled back perhaps considerably before going higher. I've been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin - jeff brown stock market prediction. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. democratic republic. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus offer forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the info depends on date as of February 2021, however we could not individually confirm this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an exact figure at this minute. Brown is best known for his sage-like capability to pick winning technology stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an outstanding perspective on the marketplace. He's constantly on the hunt for new chances, and he shares much of his finest choices in the Near Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully forecasted a few of the biggest economic occasions of the previous twenty years. Although he does not appear to release his choices to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it right every time, but Jeff Brown's accurate forecasts have actually earned him legions of dedicated followers. That says a lot about his ability. The Future Report is published by Brownstone Research, a prominent financial research publisher. Brownstone Research uses a number of research services with a variety of specializations - jeff brown top biotech stock 2021.
The company is likewise connected with Bonner & Partners, another well-respected research publisher - jeff brown. On its website, Brownstone says its mission is to supply retail investors with professional-grade research study: "For too long, the very best financial investment research study has actually not been offered to individual investors. It has actually been usually reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. melania trump. The mission of Brownstone Research is to make that type of proprietary research study available to any financiers seeking to acquire an edge in the markets. The objective is simple to deliver unique and successful financial investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise works as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After decades of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the market, you understand that he has a track record as a King Midas of sorts. jeff bezos. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown thinks S.A.V. first lady. might be "the greatest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding 2 innovative technologies: expert system and electric automobiles. Musk hopes the combination will help him establish the first fully-autonomous, self-driving automobiles ever. It's nothing except the vehicle industry's Holy Grail. As you know, electrical automobiles and self-driving automobile stocks have actually been huge this year, but the Wall Street maker has approved buzz without much concrete outcome. Despite a drastic boost in competition over the past couple of years, Brown still believes Musk has the best opportunity of putting everything together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transportation. Generally, this innovation would permit you to lease your vehicle as an autonomous, self-driving taxi when you're not using it. You merely get out of the car and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a substantial piece of the earnings. It sounds outrageous, but it could be closed than you believe.